跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Boehringer Ingelheim International Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 13, 2023
Approval ID
c03b06b6758d2cbb
Company
Boehringer Ingelheim International Gmbh
Type
Standard
Approval Details
Approval Id
c03b06b6758d2cbb
Drug Cima Aemps Name
SPEVIGO 450 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1221688001
Holder Company Name
Boehringer Ingelheim International Gmbh
Marketing Company Name
Boehringer Ingelheim Espana S.A.
Holder Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Authorization Date
2023-01-13
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
450 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Boehringer Ingelheim International Gmbh
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Company Information
Pharmaceutical Company Name
Boehringer Ingelheim International GmbH
Country Name
Germany
City Name
ingelheim am rhein,rheinland-pfalz,country_de
Address
Binger Straße 173
Website
http://www.boehringer-ingelheim.com
Active Ingredients
ESPESOLIMAB
450 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 13, 2023
Approval ID
c03b06b6758d2cbb
Type
Standard
Back to CIMA-AEMPS Approvals